Aetiology and prevention of emesis induced by radiotherapy.
The introduction of new antiemetics has resulted in renewed interest in the aetiology and control of radiation induced emesis. Studies both with fractionated treatment and with high-dose single exposures have clearly demonstrated the value of the 5HT3 receptor antagonist antiemetics. This paper reviews the selection of optimal antiemetics.
Feyer
P C
PC
Department of Radiotherapy, Medical School Charité, Humboldt University Berlin, Germany. Petra.Feyer@rz.hu-berlin.de
Stewart
A L
AL
Titlbach
O J
OJ
D000328:Adult; D000368:Aged; D000932:Antiemetics / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D019583:Dose Fractionation, Radiation; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D008875:Middle Aged; D009369:Neoplasms / Q000532:radiotherapy*; D010166:Palliative Care; D011985:Receptors, Serotonin / Q000187:drug effects; D044406:Receptors, Serotonin, 5-HT3; D012307:Risk Factors; D012702:Serotonin Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D014839:Vomiting / Q000188:drug therapy* / Q000209:etiology
D000932:Antiemetics; D011985:Receptors, Serotonin; D044406:Receptors, Serotonin, 5-HT3; D012702:Serotonin Antagonists